Your browser doesn't support javascript.
loading
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.
Alrabadi, N N; Abushukair, H M; Ababneh, O E; Syaj, S S; Al-Horani, S S; Qarqash, A A; Darabseh, O A; Al-Sous, M M; Al-Aomar, S R; Ahmed, Y B; Haddad, R; Al Qarqaz, F A.
Afiliação
  • Alrabadi NN; Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. nnalrabadi@just.edu.jo.
  • Abushukair HM; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Ababneh OE; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Syaj SS; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Al-Horani SS; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Qarqash AA; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Darabseh OA; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Al-Sous MM; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Al-Aomar SR; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Ahmed YB; Facullty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Haddad R; Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan.
  • Al Qarqaz FA; Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
Clin Transl Oncol ; 23(9): 1885-1904, 2021 Sep.
Article em En | MEDLINE | ID: mdl-33877531

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Jordânia País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Ipilimumab / Antineoplásicos Imunológicos / Nivolumabe / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Jordânia País de publicação: Itália